Synthesis and Antibacterial Activities of New Bis-benzimidazoles

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 1, 2004, Pages 64-68

  Küçükbay, Hasan ^a   Durmaz, Riza ^a   Okuyucu, Naif ^a   Günal, Selami ^a   Kazaz, Cavit ^b  

^a INONU UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Bis benzimidazole derivatives, antibacterial activity, in vitro studies, synthesis

Indexed keywords

1,1' BUTYLENEBIS(5 METHYLBENZIMIDAZOLE); 3,3' DIMETHYL 1,1' BUTYLENEBIS(5 METHYLBENZIMIDAZOLE)DIIODIDE; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; HALIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; IN VITRO STUDY; INFRARED SPECTROSCOPY; INHIBITION KINETICS; MICROANALYSIS; MINIMUM INHIBITORY CONCENTRATION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; REACTION ANALYSIS; STANDARD; STAPHYLOCOCCUS AUREUS;

EID: 0347247676     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296938     Document Type: Article

References (15)

1. Bei, F., Jian, F., Yang, X. et al., 1,4-Bis(2-benzimidazolyl)benzene. Acta Cryst. C56, 718 (2000)
2. Carlsson, E., Lindberg, P., Unge, V. S., Two of a kind. Chem. Brit. 38, 42 (2002)
3. Küçükbay, H., Çetinkaya, E., Durmaz, R., Synthesis and antimicrobial activty of substituted benzimidazoles, benzothiazoles and imidazole derivatives. Arzneim.-Forsch./Drug Res. 45 (II), 1331 (1995)
4. Çetinkaya, B., Çetinkaya, E., Küçükbay, H. et al., Antimicrobial activity of carbene complexes of rhodium (I) and ruthenium (II). Arzneim.-Forsch./Drug Res. 46 (II), 821 (1996)
5. Çetinkaya, B., Çetinkaya, E., Küçükbay, H. et al., Synthesis and antimicrobial activity of electron rich olefin derived cyclic ureas. Arzneim.-Forsch./Drug Res. 46 (II), 1154 (1996)
6. Küçükbay, H., Durmaz, B., Antifungal activity of organic and organometallic derivatives of benzimidazole and benzothiazole. Arzneim.-Forsch./Drug Res. 47 (I), 667 (1997)
7. Durmaz, R., Küçükbay, H., Çetinkaya, E. et al., Antimicrobial activity of rhodium (I) and ruthenium (II) carbene complexes derived from benzimidazole against staphylococus aureus isolates. Turk. J. Med. Chem. 27, 59 (1997)
8. Küçükbay, H., Durmaz, R., Güven, M. et al., Synthesis of some benzimidazole derivatives and their antibacterial and antifungal activities. Arzneim.-Forsch./Drug Res. 51 (I), 420 (2001)
9. Durmaz, R., Köroǧlu, M., Küçükbay, H. et al., Investigation of serum minimal inhibitory concentrations of some benzimidazole derivatives and their effects on liver and renal functions. Arzneim.-Forsch./Drug Res. 48 (II), 1179 (1998)
10. Singh, A. K., Lown, J. W., Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles. Anti-Cancer Drug Des. 15, 265 (2000)
11. Soderlind, K. J., Gorodetsky, B., Singh, A. K. et al., Bis-benzimidazole anticancer agents: targeting human tumour helicases. Anti-Cancer Drug Des. 14, 19 (1999)
12. Turner, P. R., Denny, W. A., The mutagenic properties of DNA minor-groove binding ligands. Mutat. Res. 355, 141 (1996)
13. Tidwell, R. R., Jones, S. K., Naiman, N. A. et al., Activity of cationically substituted bis-benzimidazoles against experimental pneumocystis carnii pneumonia. Antimicrob. Agents Chemother. 37, 1713 (1993)
14. Del Poeta, M., Schell, W. A., Dykstra, C. C. et al., Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents. Antimicrob. Agents Chemother. 42, 2495 (1998)
15. National Committee for Clinical Laboratory Standards (NCCLS), Methods for diluation antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M7-A2, NCCLS Villanova, PA, USA (1997)